OCS ▲ +5.5% - Oculis Holding AG
$OCS - Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis
22-OCT-2026 02:00 AM ET
Share this post
More filings for $OCS
OCS ▲ +2.8% - Oculis Holding AGOct 20, 2026OCS ▼ -1.4% - Oculis Holding AGOct 19, 2026OCS ▲ +1.6% - Oculis Holding AGOct 7, 2026OCS ▲ +2.1% - Oculis Holding AGOct 1, 2026
View full $OCS filing history →💬 Comments
Loading comments…
Leave a comment